Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results.

Autor: Yeon Hee Park1, Tae Yong Kim2, Young-Hyuck Im1, Keun-Seok Lee3, In Hae Park3, Joohyuk Sohn4, Soo-Hyeon Lee4, Seock-Ah Im2, Jee Hyun Kim5, Se Hyun Kim5, Soo Jung Lee6, Su-Jin Koh7, Ki Hyeong Lee8, Yoon Ji Choi9, Eun Kyung Cho10, Suee Lee11, Seok Yun Kang12, Jae Hong Seo13, Sung-Bae Kim14, Kyung Hae Jung14 khjung@amc.sooul.kr
Zdroj: Cancer Research & Treatment. 2017, Vol. 49 Issue 2, p423-429. 7p.
Databáze: Academic Search Ultimate